By Mike Kocsis | 7 minutes read | Last updated: October 13, 2026 Categories: Uncategorized
Medically Reviewed by Dr. George Touliatos
Retatrutide is an investigational once-weekly injection that you cannot legally buy in the UK for weight loss as of 2026. It is still being tested for its health effects, safety, quality, etc., in clinical trials and has not yet been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for medical use in the UK.
Quick facts about retatrutide:
Manufacturer: Eli Lilly
Availability in the UK: Unavailable for public use
UK launch date: Not confirmed yet
Clinical trial status: Phase 3 trials ongoing
Drug status: Investigational medication
Read the article to learn everything you need to know about retatrutide availability, prescription, licensed alternatives, and more.
Is retatrutide available in the UK?
Retatrutide is not yet available for public use in the UK or elsewhere, as its manufacturer is still testing and evaluating it through clinical trials.
It does not yet have marketing authorisation from the MHRA. Therefore, it cannot be routinely prescribed by the NHS or private clinics or dispensed by GPhC-registered pharmacies here.
Access to retatrutide is limited to eligible participants in clinical trials. Still, participation does not guarantee that you will receive retatrutide, as these trials include placebo groups as well.
Why hasn’t retatrutide been approved in the UK yet?
Retatrutide has not been approved yet because it is still being tested through Phase 3 trials, named the TRIUMPH programme. These trials involve larger groups of participants and help researchers understand retatrutide’s long-term safety, efficacy, and other effects in humans.
If these large-scale trials are completed and show positive results, Eli Lilly will then submit the scientific data to MHRA.
The MHRA is the official agency that regulates all medicines in the UK. It will review the data before deciding whether to give retatrutide a marketing authorisation or not. It may also request further information before making its decision.
Until this process is completed and authorisation is granted, retatrutide cannot be marketed in the UK.
When will retatrutide be available in the UK?
There is no confirmed launch date for retatrutide in the UK yet. Its availability will depend on the results of ongoing clinical trials and subsequent regulatory approval.
The expected timeline
Eli Lilly plans to submit an application for retatrutide’s US approval in the first quarter of 2027. The company has not announced a UK submission date, so we cannot tell exactly when it will become available here.
Various TRIUMPH programme trials show promising results. If it continues this way, Eli Lilly may submit an application to the MHRA in 2027, following its submission to the FDA. So, 2028 or later could be a possible timeframe for UK availability, with NHS access following later.
Retatrutide clinical trials, results and the latest news
Results from Eli Lilly’s retatrutide clinical trials have been published in The New England Journal of Medicine and The Lancet.
TRIUMPH-1 (obesity/overweight without type 2 diabetes patient group): In this Phase 3 trial, participants received retatrutide or placebo for 80 weeks. Average weight loss was 17.6% with 4 mg, 23.7% with 9 mg, and 25.0% with 12 mg, compared with 3.9% with placebo.
TRIUMPH-2 (obesity/overweight and type 2 diabetes patient group): Published on 29 September 2026, the trial reported that, at 80 weeks, participants taking the 12 mg dose lost an average of 20.8% of their body weight. They also experienced substantial blood sugar reduction.
TRIUMPH-4 (obesity/overweight and knee osteoarthritis patients group): This Phase 3 study investigated weight loss and knee osteoarthritis symptoms. Participants experienced up to a 75.8% reduction in WOMAC pain and 28.7% weight reduction with a 12 mg retatrutide dose.
Further clinical studies are examining retatrutide in different patient groups and its potential effects on health outcomes. Their results will show whether its potential benefits extend beyond weight loss to conditions such as cardiovascular disease, chronic kidney diseases, chronic low back pain and metabolic dysfunction-associated steatotic liver disease (MASLD).
Can you join a retatrutide trial in the UK?
There are specific criteria for participating in a retatrutide clinical trial. If you meet these eligibility criteria, you may be able to join the trial. You can check current opportunities through Be Part of Research and review each trial’s requirements before applying.
Are retatrutide pens sold online reliable?
Hundreds of websites and social media accounts are selling retatrutide online despite the lack of approval for use in the UK. Many of them are selling these products with the labels “research chemical; not for human consumption” but they are still targeting people looking for weight loss medication.
The truth is online retatrutide’s manufacturers are not affiliated with Eli Lilly – the original developer of retatrutide. Online retatrutide pens have not been tested for safety, ingredients, and quality by any regulator. So, if you take them, you never know what you are actually consuming.
Warning: Risks of buying retatrutide online
Purchasing retatrutide from online sellers has many life-threatening risks, including:
Wrong dose: Unlicensed retatrutide is not medically tested for quality, so you never know what retatrutide dose you are actually getting (if any).
Incorrect ingredients: Online retatrutide pens have been found to contain unidentified peptides.
No clinical oversight: Retatrutide is not a side-effect-free medicine. Consuming it without medical supervision means complications like pancreatitis or severe hypoglycaemia are not managed promptly and dose is not adjusted based on your needs.
What are the best licensed weight loss alternatives to retatrutide?
If you are looking for a weight management medication in the UK, here are the best licensed treatment options you can consider.
GLP-1 receptor agonists: Wegovy (semaglutide) is an MHRA-approved weight loss medication you can get from UK pharmacy with a prescription or NHS specialist services.
Dual agonists: With the ability to cause up to 15% to 22.5% weight loss, Mounjaro (tirzepatide) is the most effective licensed weight loss medication available in the UK. It is a dual agonist, meaning it targets two hormone receptors – GLP-1 and GIP.
| Medication | Wegovy | Mounjaro | Retatrutide |
| Active ingredient | Semaglutide | Tirzepatide | Retatrutide |
| Type of medication | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist | Triple GIP/GLP-1/glucagon receptor agonist |
| UK approval | Approved, regulated medicine | Approved, regulated medicine | Not approved yet |
| Average weight loss in trials | Up to 14.9% | Up to 22.5% | Up to 28.3% |
Summary
Retatrutide is a triple agonist, meaning it targets three hormone receptors, i.e., glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GIP-1) and glucagon receptors to help control hunger and cause weight loss. It has shown up tp 28.3% average weight loss in clinical trials, exceeding results reported for currently licensed options for weight loss.
Retatrutide is still going through the trial phase, so it is currently unavailable for human use in the UK and the entire world. Hence, no doctor can legally prescribe it until it gets marketing authorisation.
People looking for licensed weight loss solutions should consider UK-approved options like Mounjaro. They are backed by clinical evidence and can be prescribed legally to eligible patients with ongoing monitoring and medical supervision.
Book a consultation with us today to learn more about approved weight reduction options available in the UK.
FAQs about retatrutide availability in the UK
Is retatrutide FDA approved?
No, retatrutide has not been approved by the FDA or any other regulatory authorities, as of 2026.
Is retatrutide illegal in the UK?
Selling or prescribing retatrutide is illegal in the UK because it is an investigational drug that the MHRA or NICE has not approved for any medical use.
How to get a retatrutide prescription?
You cannot get a legal retatrutide prescription in the UK or anywhere in the world. Currently, the only legal way to access it is through eligible clinical trials, where participants may receive either retatrutide or a placebo.
Can doctors prescribe retatrutide?
No, doctors or any qualified healthcare professional cannot prescribe retatrutide as of yet.
Can you buy retatrutide on the NHS?
No, currently, retatrutide is not available on the NHS.
Is buying retatrutide online safe?
Buying retatrutide is very unsafe because products sold through these websites contain incorrect doses, bacterial growth, harmful ingredients, or even no retatrutide at all.
Where to buy Retatrutide online?
You will find many online sellers providing retatrutide. None of them is an authorised source for retatrutide. Therefore, it is best to stay away from them and instead look for safer options like Mounjaro that is approved and produces great results.
Is retatrutide available on the black market?
Yes, the news says it is available through unregulated black markets. Buying it from there poses serious risks.
Why are websites selling retatrutide if it is not approved?
Various online platforms are selling products labelled as retatrutide because of the hype surrounding it. These products have not been assessed for safety, quality, and efficacy by any regulator.
References
Bellido, V., le Roux, C.W., Ekinci, E.I., Bjornstad, P., Frias, J.P., Giblin, K., Eyde, S., Park, S.Y., Ferro, J., Johnson, C. and Taylor, A., 2026. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial. The Lancet.
Bajaj, H.S., Welch, M., Shah, P., Luna, E., Jaouimaa, F.Z., Liu, B., Liu, R., Chen, Y., Patel, H. and Bartee, A., 2026. Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial. The Lancet, 407(10546), pp.2402-2413.
Jastreboff, A.M., Kaplan, L.M., Davies, M.J., Wilding, J.P., Ahmad, N.N., Murray, M., Du, Y., Makarova, N., Giblin, K., Schloot, N.C. and Wang, Y., 2026. Retatrutide, a triple hormone receptor agonist, for treatment of obesity. N Engl J Med.
https://investor.lilly.com/node/54981
Evidence Based Research
This article has been researched and written based on scientific evidence and fact sheets that have then been crossed checked by our team of doctors and subject matter experts.
References, sources and studies used alongside our own in-house research have been cited below, most of which contain external clickable links to reviewed scientific paper that contain date stamped evidence.
Our team of healthcare experts and GMC registered doctors are licensed to UK GMC standards. We strive to provide you with the latest evidence based, researched articles that are unbiased, honest and provide you with accurate insights, statistics and helpful information on the discussed topic to ensure you gain a better understanding of the subject. You can read more about our Editorial Process by clicking here.
We value your feedback on our articles, if you have a well-researched paper you would like to share with us please contact us.
Quick Low Testosterone Test
If you know your total testosterone reading from a previous blood test input the results to the left above to see if your testosterone levels are normal.
Low Testosterone Levels
You may have low testosterone depending on the symptoms you have, please contact us to find out how we can help.
Please Retry
The Total Testosterone Level You Entered Is Incorrect. Figure Must be in nmol/L you can use our converter here.
Normal Testosterone Levels
Your testosterone levels appear to be in the normal range.
LOOKING GOOD!
You must be over 38, have had your ovaries removed or have suffered with premature menopause to warrant further hormone tests.
Further investigation needed
Please contact us to discuss your hormones, we need your total testosterone levels to validate your hormone deficiency. You can order a blood test here.
Low Testosterone Levels
You may have low testosterone depending on the symptoms you have, please contact us to find out how we can help.
High Testosterone Levels
You appear to have higher than normal testosterone levels, please contact us for further investigation.
Normal Testosterone Levels
You appear to have normal testosterone levels. Contact us if you have any concerns.
About the Author: Mike Kocsis
Mike Kocsis has an MBA with a focus on healthcare administration and is an entrepreneur and medical case manager for Balance My Hormones which offers medical services in the UK and Europe. Mike has over 25 years of experience in the healthcare sector, much of that working with people who have hormone imbalances. Mike has appeared on podcasts and radio and is an expert speaker on the subject of hormone imbalance. He specialises in Testosterone Replacement Therapy and Hormone Replacement Therapy (HRT) and with his first-hand experience he has helped thousands of people suffering from low testosterone recover and regain control of their lives. You can follow him on LinkedIn and on the Balance My Hormones YouTube Channel.
Last update: October 13th, 2026
